STAT3 and rheumatoid arthritis: Although constitutive STAT3 phosphorylation in CD4+ T cells of RA patients with recent-onset disease was clear in the present study and the previous studies [23,33,34], it was not evident in a recent study of RA patients refractory to DMARD therapy [55].